Fate Therapeutics, Inc. (FATE)
1.38
-0.02
(-1.43%)
USD |
NASDAQ |
Feb 20, 12:09
Fate Therapeutics Total Assets (Quarterly) : 343.67M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| MannKind Corp. | 494.64M |
| Vertex Pharmaceuticals, Inc. | 26.14B |
| Ardelyx, Inc. | 486.17M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 109.60M |
| Shareholders Equity (Quarterly) | 234.07M |
| Debt to Equity Ratio | 0.3386 |
| Current Ratio | 7.871 |
| Net Debt Paydown Yield | 2.93% |